This Mesoblast Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

• Jefferies analyst David Stanton downgraded the rating for Mesoblast Limited (NASDAQ:MESO) from Buy to Hold. Mesoblast shares closed at $14.63 on Friday. See how other analysts view this stock.
• William Blair analyst Sami Corwin downgraded Applied Therapeutics, Inc. (NASDAQ:APLT) from Outperform to Market Perform. Applied Therapeutics shares closed at $0.8801 on Friday. See how other analysts view this stock.
• BTIG analyst Thomas Catherwood downgraded the rating for Innovative Industrial Properties, Inc. (NYSE:IIPR) from Buy to Neutral. NCR Atleos shares closed at $73.66 on Friday. See how other analysts view this stock.

Considering buying MESO stock? Here’s what analysts think:

Read This Next:

• Jim Cramer Likes Walmart, Recommends Buying This ‘Very, Very Good’ Financial Stock